119 related articles for article (PubMed ID: 17538565)
21. Interleukin (IL)-23 p19 expression induced by IL-1beta in human fibroblast-like synoviocytes with rheumatoid arthritis via active nuclear factor-kappaB and AP-1 dependent pathway.
Liu FL; Chen CH; Chu SJ; Chen JH; Lai JH; Sytwu HK; Chang DM
Rheumatology (Oxford); 2007 Aug; 46(8):1266-73. PubMed ID: 17569750
[TBL] [Abstract][Full Text] [Related]
22. Induction of CCL13 expression in synovial fibroblasts highlights a significant role of oncostatin M in rheumatoid arthritis.
Hintzen C; Quaiser S; Pap T; Heinrich PC; Hermanns HM
Arthritis Rheum; 2009 Jul; 60(7):1932-43. PubMed ID: 19565514
[TBL] [Abstract][Full Text] [Related]
23. Factors underlying chronic inflammation in rheumatoid arthritis.
Wong SH; Lord JM
Arch Immunol Ther Exp (Warsz); 2004; 52(6):379-88. PubMed ID: 15577739
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-18 and the treatment of rheumatoid arthritis.
Dinarello CA
Rheum Dis Clin North Am; 2004 May; 30(2):417-34, ix. PubMed ID: 15172050
[TBL] [Abstract][Full Text] [Related]
25. Cytokine network and its manipulation in rheumatoid arthritis.
Malaviya AM
J Assoc Physicians India; 2006 Jun; 54 Suppl():15-8. PubMed ID: 16909710
[TBL] [Abstract][Full Text] [Related]
26. Physiology of cytokine pathways in rheumatoid arthritis.
Arend WP
Arthritis Rheum; 2001 Feb; 45(1):101-6. PubMed ID: 11308054
[TBL] [Abstract][Full Text] [Related]
27. IL-2 activation of STAT5 enhances production of IL-10 from human cytotoxic regulatory T cells, HOZOT.
Tsuji-Takayama K; Suzuki M; Yamamoto M; Harashima A; Okochi A; Otani T; Inoue T; Sugimoto A; Motoda R; Yamasaki F; Nakamura S; Kibata M
Exp Hematol; 2008 Feb; 36(2):181-92. PubMed ID: 18023521
[TBL] [Abstract][Full Text] [Related]
28. Biologic therapies on the horizon for rheumatoid arthritis.
Moreland LW
J Clin Rheumatol; 2004 Jun; 10(3 Suppl):S32-9. PubMed ID: 17043499
[TBL] [Abstract][Full Text] [Related]
29. [Rituximab (Mabthera)--treatment of rheumatoid arthritis patients with inadequate response to TNF inhibitors--when to change therapy?].
Morović-Vergles J
Reumatizam; 2008; 55(2):70-2. PubMed ID: 19024280
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-7 in rheumatoid arthritis.
Churchman SM; Ponchel F
Rheumatology (Oxford); 2008 Jun; 47(6):753-9. PubMed ID: 18356170
[TBL] [Abstract][Full Text] [Related]
31. [Biopharmaceuticals in the treatment of rheumatoid arthritis].
Baslund B; Bendtzen K
Ugeskr Laeger; 2008 Jun; 170(24):2108-10. PubMed ID: 18572481
[TBL] [Abstract][Full Text] [Related]
32. Cytokines as potential therapeutic targets for inflammatory skin diseases.
Numerof RP; Dinarello CA; Asadullah K
Eur Cytokine Netw; 2005 Jun; 16(2):101-3. PubMed ID: 15941680
[TBL] [Abstract][Full Text] [Related]
33. Cytokines in the pathogenesis of rheumatoid arthritis.
McInnes IB; Schett G
Nat Rev Immunol; 2007 Jun; 7(6):429-42. PubMed ID: 17525752
[TBL] [Abstract][Full Text] [Related]
34. Signal transduction in rheumatoid arthritis.
Sweeney SE; Firestein GS
Curr Opin Rheumatol; 2004 May; 16(3):231-7. PubMed ID: 15103250
[TBL] [Abstract][Full Text] [Related]
35. Emerging cell and cytokine targets in rheumatoid arthritis.
Burmester GR; Feist E; Dörner T
Nat Rev Rheumatol; 2014 Feb; 10(2):77-88. PubMed ID: 24217582
[TBL] [Abstract][Full Text] [Related]
36. Signal transduction networks in rheumatoid arthritis.
Hammaker D; Sweeney S; Firestein GS
Ann Rheum Dis; 2003 Nov; 62 Suppl 2(Suppl 2):ii86-9. PubMed ID: 14532158
[TBL] [Abstract][Full Text] [Related]
37. Rheumatoid arthritis.
Gay S
Curr Opin Rheumatol; 2001 May; 13(3):191-2. PubMed ID: 11333347
[No Abstract] [Full Text] [Related]
38. Emerging biologic therapies in rheumatoid arthritis: cell targets and cytokines.
Singh R; Robinson DB; El-Gabalawy HS
Curr Opin Rheumatol; 2005 May; 17(3):274-9. PubMed ID: 15838236
[TBL] [Abstract][Full Text] [Related]
39. Signal transduction pathways and transcription factors as therapeutic targets in inflammatory disease: towards innovative antirheumatic therapy.
Tas SW; Remans PH; Reedquist KA; Tak PP
Curr Pharm Des; 2005; 11(5):581-611. PubMed ID: 15720277
[TBL] [Abstract][Full Text] [Related]
40. Intracellular signal pathways: potential for therapies.
Mavers M; Ruderman EM; Perlman H
Curr Rheumatol Rep; 2009 Oct; 11(5):378-85. PubMed ID: 19772834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
